Evidence map›Paper›PMID 9448281›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes.

M Gao, P Ping, S Post, P A Insel, R Tang, H K Hammond

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 127 citations in OpenAlex.

  1. Trial
  2. Past, Present and Future of Regenerative Gene Therapy for Ischemic Heart Failure.Journal of cardiovascular translational research · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Current Landscape of Heart Failure Gene Therapy.Journal of the American Heart Association · 2019
    Review
  7. Function of Adenylyl Cyclase in Heart: the AKAP Connection.Journal of cardiovascular development and disease · 2018
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M GaoSan Diego Veterans Affairs Medical Center, San Diego, CA 92161, USA.
P Ping
S Post
P A Insel
R Tang
H K Hammond
University of Louisville · USUniversity of California, San Diego · US

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
SCOR IN HEART FAILUREP50HL053773 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI CHIEN, KENNETH R · 1995 to 2004
$5.8M
ADENYLYL CYCLASE/BETA-ADRENERGIC RECEPTOR KINASE IN CHFF32HL009097 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI PING, PEIPEI · 1994 to 1994
–
NHLBI NIH HHS 1 P50 HL-53773-01NHLBI NIH HHS F32 HL009097NHLBI NIH HHS HL02812-01NHLBI NIH HHS HL09097-01NHLBI NIH HHS P50 HL053773NHLBI NIH HHS T32 HL007444
6 · The paper itself

Abstract

Cellular content of cAMP generated by activation of adenylylcyclase (AC; EC 4.6.1.1) is a key determinant of functional responsiveness in the heart and other tissues. We have tested two hypotheses regarding the relationship between AC content and beta-adrenergic receptor (betaAR)-mediated signal transduction in cardiac myocytes. First, that AC content limits adrenergic signal transduction, and, second, that increased AC, independent of (betaAR) number and G-protein content, yields a proportional increase in betaAR-mediated transmembrane signaling. We used recombinant adenovirus to increase AC isoform VI (ACVI) expression in neonatal cardiac myocytes. Cells that overexpressed ACVI responded to agonist stimulation with marked increases in cAMP production in proportion to protein expressed. In parallel experiments performed on cells transfected with lacZ (control) or ACVI, [3H]forskolin binding, used to assess AC protein expression, was amplified 6-fold, while betaAR-stimulated cAMP production from these cells was increased 7-fold. No changes in betaAR number, or in the heterotrimeric GTP-binding proteins, Galphas or Galphai2, were observed. Previous studies indicate that increased cardiac expression of betaAR or Galphas does not yield proportional increases in transmembrane adrenergic signaling. In contrast, the current data demonstrate that increased ACVI expression provides a proportional increase in beta-adrenergic signal transduction. Our results show that the amount of AC sets a limit on transmembrane beta-adrenergic signaling. We speculate that similar functional responses are possible in other cell types in which AC plays an important physiological role.

Indexed as

Adenylyl CyclasesAnimalsAnimals, NewbornColforsinCyclic AMPGene Expression Regulation, EnzymologicGTP-Binding ProteinsHeart FailureIsoenzymesMiceMyocardiumPolymerase Chain ReactionRatsRats, Sprague-DawleyReceptors, Adrenergic, betaSignal TransductionAdenylyl CyclasesColforsinCyclic AMPGTP-Binding ProteinsIsoenzymesReceptors, Adrenergic, beta

Identifiers

PMID9448281
PMCPMC18663
OpenAlexW2007098938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.